Membrane permeabilization by multivalent anti-microbial peptides

Protein and Peptide Letters

Volumn 16, Issue 7, 2009, Pages 736-742

  Pieters, Roland J ^a   Arnusch, Christopher J ^a,b   Breukink, Eefjan ^b  

^a UTRECHT UNIVERSITY   (Netherlands)

^b UTRECHT UNIVERSITY   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIMICROBIAL CATIONIC PEPTIDE;

AMINO ACID SEQUENCE; ARTICLE; CELL MEMBRANE PERMEABILITY; CHEMISTRY; DRUG EFFECT; HUMAN; METABOLISM; MICROBIOLOGICAL EXAMINATION; MOLECULAR GENETICS;

AMINO ACID SEQUENCE; ANTIMICROBIAL CATIONIC PEPTIDES; CELL MEMBRANE PERMEABILITY; HUMANS; MICROBIAL SENSITIVITY TESTS; MOLECULAR SEQUENCE DATA;

BACTERIA (MICROORGANISMS);

EID: 67849089171     PISSN: 09298665     EISSN: None     Source Type: Journal    
DOI: 10.2174/092986609788681841     Document Type: Article

References (37)

1. Giuliani, A.; Pirri, G.; Nicoletto, S. F. Antimicrobial peptides: an overview of a promising class of therapeutics. Centr. Eur. J. Biol., 2007, 2(1), 1-33.
2. Zasloff, M. Antimicrobial peptides of multicellular organisms. Nature, 2002, 415(6870), 389-395.
3. Zasloff, M. Magainins, a class of antimicrobial peptides from Xenopus skin: isolation, characterization of two active forms, and partial cDNA sequence of a precursor. Proc. Natl. Acad. Sci. USA, 1987, 84(15), 5449-5453.
4. Lehrer, R. I. Primate defensins. Nat. Rev. Microbiol., 2004, 2(9), 727-738
5. Rao, J.; Lahiri, J.; Isaacs, L.; Weis, R. M.; Whitesides, G. M. A trivalent system from vancomycin D-Ala-D-Ala with higher affinity than avidin-biotin. Science, 1998, 280(5364), 708-711.
6. Schaschke, N.; Matschiner, G.; Zettl, F.; Marquardt, U.; Bergner, A.; Bode, W.; Sommerhoff, C. P.; Moroder, L. Bivalent inhibition of human β-tryptase. Chem. Biol., 2001, 8(4), 313-327.
7. Profit, A. A.; Lee, T. R.; Lawrence, D. S. Bivalent inhibitors of protein tyrosine kinases. J. Am. Chem. Soc., 1999, 121(2), 280-283.
8. Kitov, P. I.; Sadowska, J. M.; Mulvey, G.; Arnstrong, G. D.; Ling, H.; Pannu, N. S.; Read; R. J.; Bundle, D. R. Shiga-like toxins are neutralized by tailored multivalent carbohydrate ligands. Nature, 2000, 403(6770), 669-672.
9. Fan, E.; Zhang, Z.; Minke, W. E.; Hou, Z.; Verlinde, C. L. M. J.; Hol, W. G. J. High-affinity pentavalent ligands of Escherichia coli heat-labile enterotoxin by modular structure-based design. J. Am. Chem. Soc., 2000, 122(11), 2663-2664.
10. Pukin, A. V.; Branderhorst, H. M.; Sisu, C.; Weijers, C. A. G. M.; Gilbert, M.; Liskamp, R. M. J.; Visser, G. M.; Zuilhof, H.; Pieters, R. J. Strong inhibition of cholera toxin by multivalent GM1 derivatives. ChemBioChem, 2007, 8(13), 1500-1503.
11. Tam, J. P.; Lu, Y.-A.; Yang, J.-L. Antimicrobial dendritic peptides. Eur. J. Biochem., 2002, 269(3), 923-932.
12. Nakamura, T.; Furanaka, H.; Miyata, T.; Tokunaga, F.; Muta, T.; Iwanaga, S. Tachyplesin, a class of antimicrobial peptide from the hemocytes of the horseshoe crab (Tachypleus tridentatus). Isolation and chemical structure. J. Biol. Chem., 1988, 263(32), 16709-16713.
13. Kokryakov, V. N.; Harwig, S. S. L.; Panyutich, E. A.; Shevchenko, A. A.; Aleshina, G. M.; Shamova, O. V.; Korneva, H. A.; Lehrer, R. I. Protegrins: leukocyte antimicrobial peptides that combine features of corticostatic defensins and tachyplesins. FEBS Lett., 1993, 327(2), 231-236.
14. Tang, Y.-Q.; Yuan, J.; Ösapay, G.; Ösapay, K.; Tran, D.; Miller, C. J.; Ouellette, A. J.; Selsted, M. E. A Cyclic Antimicrobial peptide produced in primate leukocytes by the ligation of two truncated adefensins. Science, 1999, 286(5439), 498-502.
15. Janiszewska, J.; Swieton, J.; Lipkowski, A. W.; Urbanczyk-Lipkowska, Z. Low molecular mass peptide dendrimers that express antimicrobial properties Bioorg. Med. Chem. Lett., 2003, 13(21), 3711-3713.
16. Janiszewska, J.; Urbanczyk-Lipkowska, Z. Amphiphilic dendrimeric peptides as model non-sequential pharmacophores with antimicrobial properties. J. Mol. Microbiol. Biotechnol., 2007, 13(4), 220-225.
17. Klajnert, B.; Janiszewska, J.; Urbanczyk-Lipkowska, Z.; Bryszewska, M.; Shcharbin, D.; Labieniec, M. Biological properties of low molecular mass peptide dendrimers. Int. J. Pharm., 2006, 309(1-2), 208-217.
18. Liu, Z.; Deshazer, H.; Rice, A. J.; Chen, K.; Zhou, C.; Kallenbach, N. R. Multivalent antimicrobial peptides from a reactive polymer scaffold. J. Med. Chem., 2006, 49(12), 3436-3439.
19. Liu, Z.; Young, A. W.; Hu, P.; Rice, A. J.; Zhou, C.; Zhang, Y.; Kallenbach, N. R. Tuning the membrane selectivity of antimicrobial peptides by using multivalent design. ChemBioChem, 2007, 8(17), 2063-2065.
20. Khrushchev, A. Y.; Kashparov, I. A.; Klimenko, L. V.; Mitin Yu. V. Branched antimicrobial peptides. Russ. J. Bioorg. Chem., 2007, 33(6), 544-548.
21. Pini, A.; Giuliani, A.; Falciani, C.; Runci, Y.; Ricci, C.; Lelli, B.; Malossi, M.; Neri, P.; Sossolini, G. M.; Bracci, L. Antimicrobial activity of novel dendrimeric peptides obtained by phage selection and rational modification. Antimicrob. Agents Chemother., 2005, 49(7), 2665-2672.
22. Pini, A.; Giuliani, A.; Falciani, C.; Fabbrini, M.; Pileri, S.; Lelli, B.; Bracci, L. Characterization of the branched antimicrobial pepti-de M6 by analyzing its mechanism of action and toxicity. J. Pept. Sci., 2007, 13(6), 393-399.
23. Sal-Man, N.; Oren, Z.; Shai, Y.; Preassembly of membrane-active peptides is an important factor in their selectivity toward target cells. Biochemistry, 2002, 41(39), 11921-11930.
24. Dempsey, C. E.; Ueno, S.; Avison, M. B. Enhanced membrane permeabilization and antibacterial activity of a disulfide-dimerized magainin analogue. Biochemistry, 2003, 42(2), 402-409.
25. Mukai, Y.; Matsushita, Y.; Niidome, T.; Hatekeyama, T.; Aoyagi, H. Parallel and antiparallel dimers of magainin 2: their interaction with phospholipid membrane and antibacterial activity J. Pept. Sci., 2002, 8(10), 570-577.
26. Hornef, M. W.; Pütsep, K.; Karlsson, J.; Refai, E.; Andersson, M. Increased diversity of intestinal antimicrobial peptides by covalent dimer formation. Nat. Immunol., 2004, 5(8), 836-843.
27. Glukhov, E.; Stark, M.; Burrows, L.; Deber, C. M. Basis for selectivity of cationic antimicrobial peptides for bacterial versus mamalian membranes J. Biol. Chem., 2005, 280(40), 33960-33967.
28. Leontiadou, H.; Mark, A. E.; Marrink, S. J. Antimicrobial peptides in action. J. Am. Chem. Soc., 2006, 128(37), 12156-12161.
29. Arnusch, C. J.; Branderhorst, H. M.; de Kruijff, B.; Liskamp, R. M. J.; Breukink, E.; Pieters, R. J. Enhanced membrane pore formation by multimeric/oligomeric antimicrobial peptides. Biochemistry, 2007, 46(46), 13437-13442.
30. Brouwer, A. J.; Mulders, S. J. E.; Liskamp, R. M. J. Convergent synthesis and diversity of amino acid based dendrimers. Eur. J. Org. Chem., 2001, (10), 1903-1915.
31. Rostovtsev, V. V.; Green, L. G.; Fokin, V. V.; Sharpless, K. B. A stepwise Huisgen cycloaddition process: Copper(I)-catalyzed regioselective "ligation" of azides and terminal alkynes. Angew. Chem., Int. Ed., 2002, 41(14), 2596-2599.
32. Tornoe, C. W.; Christensen, C.; Meldal, M. Peptidotriazoles on solid phase: [1,2,3]-triazoles by regiospecific copper(I)-catalyzed 1,3-dipolar cycloadditions of terminal alkynes to azides. J. Org. Chem., 2002, 67(9), 3057-3069.
33. Pieters, R. J.; Rijkers, D. T. S.; Liskamp, R. M. J. Application of the 1,3-dipolar cycloaddition reaction in chemical biology: approaches towards multivalent carbohydrates and peptides and peptidebased polymers. QSAR. Comb. Sci., 2007, 26(11-12), 1181-1190.
34. Link, A. J.; Vink, M. K. S.; Tirrell, D. A. Presentation and detection of azide functionality in bacterial cell surface proteins. J. Am. Chem. Soc., 2004, 126(34), 10598-10602.
35. Papo, N.; Shai, Y. Can we predict biological activity of antimicrobial peptides from their interaction with model phospholipid membranes. Peptides, 2003, 24(11), 1693-1703.
36. Marquette, A.; Mason, A. J.; Bechinger, B. Aggregation and membrane permeabilizing properties of designed histidine-containing cationic linear peptide antibiotics. J. Pept. Sci., 2008, 144(4), 488-495.
37. Mason, A. J.; Gasnier, C.; Kichler, A.; Prévost, G.; Aunis, D.; Metz-Boutigue, M.-H.; Bechinger, B. Enhanced membrane disruption and antibiotic action against pathogenic bacteria by designed histidine-rich peptides at acidic pH. Antimicrob. Agents Chemother., 2006, 50(10), 3305-3311.